This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Theravance, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Lisa Williams
Introduction
Lisa Williams is a notable inventor based in Santa Clara, CA. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on crystalline forms of a dimethylphenyl compound. Her research and inventions have the potential to impact the treatment of various pulmonary disorders.
Latest Patents
Lisa holds a patent for her invention titled "Crystalline forms of a dimethylphenyl compound." This invention relates to crystalline free base forms of biphenyl-2-ylcarbamic acid 1-[2-(4-{[(R)-2-(3-formylamino-4-hydroxyphenyl)-2-hydroxyethylamino]methyl}-2,5-dimethylphenylcarbamoyl)ethyl]piperidin-4-yl ester or a solvate thereof. The patent also encompasses pharmaceutical compositions containing or prepared from such crystalline forms, as well as processes and intermediates useful for preparing these forms. Furthermore, it outlines methods for using these crystalline forms to treat pulmonary disorders.
Career Highlights
Lisa is currently employed at Theravance, Inc., where she continues to advance her research and development efforts. Her work has garnered attention in the pharmaceutical industry, showcasing her dedication to innovation and improving patient outcomes.
Collaborations
Lisa collaborates with talented individuals such as Jennifer Bolton and Richard D. Wilson. These partnerships enhance her research capabilities and contribute to the success of her projects.
Conclusion
Lisa Williams exemplifies the spirit of innovation in the pharmaceutical field. Her contributions through her patent and collaborations highlight her commitment to advancing medical science and improving treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
